Evidence map›Paper›PMID 7750204›Full record

ArticleClinical & experimental metastasis1995

Phenotypic variations and differential migration of NIH:OVCAR-3 ovarian carcinoma cells isolated from athymic mice.

A L Veatch, L F Carson, S Ramakrishnan

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Clinical & experimental metastasis, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. In-labeled KCCYSL peptide as an imaging probe for ErbB-2-expressing ovarian carcinomas.Journal of labelled compounds & radiopharmaceuticals · 2009
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

A L VeatchDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, USA.
L F Carson
S Ramakrishnan
University of Minnesota · USUniversity of Minnesota Medical Center · US

Funding

INHIBITION OF TUMOR CELL GROWTH BY IMMUNOTOXINSR01CA048068 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI RAMAKRISHNAN, SUNDARAM · 1988 to 1994
–
NCI NIH HHS CA 48068
6 · The paper itself

Abstract

Transplantation of the human ovarian adenocarcinoma cell line, NIH:OVCAR-3 into athymic mice produces two morphologically distinct tumor cell populations (ascites and solid tumors). In the present study, we isolated both tumor cell phenotypes and investigated their relative malignant potential. Since cytoskeletal and morphological changes correlate with metastatic phenotype, expression of the intermediate-filament protein vimentin was compared between ascites and solid tumors. Ascites tumor cells showed a less differentiated epithelial morphology and concurrently expressed higher levels of vimentin. Ascites cells were more efficient in anchorage independent growth when compared with their solid tumor counterpart. Ascites tumor cells were also highly motile compared with the solid tumor cell population (P = 0.006). Migration of ascites tumor cells was further enhanced by type IV collagen, hyaluronic acid, and chondroitin sulfate A. Solid tumor cells removed from the same animal, however, were not significantly affected by these agents. From these studies, we conclude that ovarian cancer cells present in ascites are phenotypic variants which are highly motile compared with solid tumor cells isolated from the same animal. Ascites tumor cells with increased motility may contribute to peritoneal seeding and metastasis.

Indexed as

AdenocarcinomaAnimalsAscitesCell DivisionCell MovementCytoskeletonFemaleGenetic VariationHumansMiceMice, Inbred BALB CMice, NudeNeoplasm TransplantationOvarian NeoplasmsPhenotypeTumor Cells, CulturedVimentin

Identifiers

PMID7750204
OpenAlexW2076954712

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.